BlackRock Inc. - ACHILLES THERAPEUTICS PLC ownership

ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 26 filers reported holding ACHILLES THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ACHILLES THERAPEUTICS PLC
ValueSharesWeighting
Q3 2022$572,000
-12.8%
253,112
-2.8%
0.00%
Q2 2022$656,000
-16.3%
260,403
-2.3%
0.00%
Q1 2022$784,000
-26.3%
266,657
+25.5%
0.00%
Q4 2021$1,064,000
+336.1%
212,432
+749.7%
0.00%
Q2 2021$244,000
-40.9%
25,0000.0%0.00%
Q1 2021$413,00025,0000.00%
Other shareholders
ACHILLES THERAPEUTICS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 11,086,909$55,545,00053.06%
RA Capital Management 5,014,687$25,124,0000.44%
Artal Group S.A. 2,255,375$11,299,0000.31%
Redmile Group, LLC 2,088,089$10,461,0000.24%
Orbimed Advisors 1,584,845$7,940,0000.10%
Sender Co & Partners, Inc. 27,690$139,0000.07%
Baker Brothers Advisors 2,591,366$12,983,0000.06%
Perceptive Advisors 1,510,750$7,568,0000.06%
Woodline Partners LP 324,387$1,625,0000.02%
Point72 Asset Management, L.P. 1,000,000$5,010,0000.02%
View complete list of ACHILLES THERAPEUTICS PLC shareholders